We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current CNCR market cap is 12.03M. The company's latest EPS is USD -5.7713 and P/E is -2.61.
| Quarter End | |||||
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | |||||
| Operating Income | |||||
| Net Income |
| Year End August 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 224k | 177k | 190k | 153k | 70k |
| Operating Income | 0 | 0 | 0 | 0 | 0 |
| Net Income | -13.61M | 10.92M | 5.7M | -17.58M | -4.62M |
| Quarter End | |||||
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | |||||
| Total Liabilities | |||||
| Total Equity |
| Year End August 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 35.2M | 40.32M | 44.47M | 23.25M | 9.65M |
| Total Liabilities | 1.01M | 26k | 29k | 17k | 6k |
| Total Equity | 34.2M | 40.29M | 44.44M | 23.23M | 9.64M |
| Market Cap | 12.03M |
| Price to Earnings Ratio | -2.61 |
| Price to Sales Ratio | 171.89 |
| Price to Cash Ratio | 0 |
| Price to Book Ratio | 1.25 |
| Dividend Yield | - |
| Shares Outstanding | 800k |
| Average Volume (1 week) | 7.37k |
| Average Volume (1 Month) | 10.42k |
| 52 Week Change | 12.32% |
| 52 Week High | 18.00 |
| 52 Week Low | 9.22 |
| Spread (Intraday) | 7.31 (34.81%) |
| Company Name | ETF Series Solutions Trust Range Cancer Therapeutics |
| Address |
615 east michigan st milwaukee, wisconsin 53202 |
| Website | https://www.loncarfunds.com |
| Industry | mgmt invt offices, open-end (6722) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
